<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02686710</url>
  </required_header>
  <id_info>
    <org_study_id>GSK-TV-L</org_study_id>
    <nct_id>NCT02686710</nct_id>
  </id_info>
  <brief_title>Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients</brief_title>
  <official_title>Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</source>
  <brief_summary>
    <textblock>
      Assessment of GSK-3beta contents in leukocytes in on-pump cardiosurgical patients receiving
      either volatile or intravenous anesthesia
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gsk-3beta base line content</measure>
    <time_frame>base line</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Gsk-3beta content after induction</measure>
    <time_frame>20 minutes after tracheal intubation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Gsk-3beta content after surgery</measure>
    <time_frame>immediately after surgery</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">21</enrollment>
  <condition>Glycogen Synthase Kinase 3</condition>
  <arm_group>
    <arm_group_label>VIMA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patiens receiving volatile induction and maitenance of anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TIVA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patiens receiving total intravenous anesthesia based on propofol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combi</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patiens receiving total intravenous induction and volatile anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <arm_group_label>VIMA</arm_group_label>
    <arm_group_label>Combi</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <arm_group_label>TIVA</arm_group_label>
    <arm_group_label>Combi</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        elective on-pump CABG

        Exclusion Criteria:

        re-operation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</name>
      <address>
        <city>Moscow</city>
        <zip>129110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oleg Grebenchikov, MD</last_name>
      <phone>+7 965 110 52 98</phone>
      <email>oleg.grebenchikov@yandex.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2016</study_first_submitted>
  <study_first_submitted_qc>February 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2016</study_first_posted>
  <last_update_submitted>February 16, 2016</last_update_submitted>
  <last_update_submitted_qc>February 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</investigator_affiliation>
    <investigator_full_name>Oleg A. Grebenchikov</investigator_full_name>
    <investigator_title>senior researcher, Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

